Device Trial Radar · NCT02447120
Topcon 3D OCT-1 Maestro Reference Database Study II
Last checked: Nov 19, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
504
Actual
Start
May 2015
Primary completion
Oct 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Topcon Medical Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.
Conditions
- Healthy
Interventions
3D OCT-1 MaestroDevice
OCT machines used for diagnostic purposes
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retinal ThicknessTime frame: 1 minute
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
UAB School of Optometry
Birmingham, Alabama
Southern California College of Optometry
Fullerton, California
Valley Eyecare Center
Livermore, California
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.